Zobrazeno 1 - 10
of 25
pro vyhledávání: '"L. P. Papayan"'
Autor:
S. I. Kapustin, A. A. Vilnits, Zh. Yu. Sidorova, V. N. Chebotkevich, L. P. Papayan, L. A. Alekseeva, N. V. Skripchenko, S. S. Bessmeltsev
Publikováno v:
Журнал инфектологии, Vol 11, Iss 4, Pp 72-78 (2019)
Aim: To investigate the features of allelic polymorphism, of several immune- and hemostasis-related genes in children with generalized, meningococcal infections and. to assess the usefulness of genotyping for prediction, of severe disseminated intrav
Externí odkaz:
https://doaj.org/article/9f8f8e032aa44f78be457b6193dfba1b
Autor:
Kh. A. Gamzatov, D. V. Gurzhy, S. M. Lazarev, Yu. A. Namestnikov, A. A. Lerner, L. P. Papayan, O. G. Golovina, E. A. Khait, O. A. Smirnova, O. Yu. Matvienko
Publikováno v:
Вестник хирургии имени И.И. Грекова, Vol 172, Iss 5, Pp 066-070 (2018)
Generally recognized factor, which complicates the course of sepsis, is the development of hypercoagulation syndrome. The increase of thrombin coagulation indicates on the elevation of risk of thrombus formation in microcirculation vessels, which cou
Externí odkaz:
https://doaj.org/article/4223c0e2aade4d1c8bc5be13000680b6
Autor:
G. A. Berezovskaya, N. N. Petrischev, L. P. Papayan, M. A. Karpenko, O. A. Smirnova, T. V. Lazovskaya, O. S. Napalkova
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 115-123 (2015)
This study is aimed at exploring the use of thrombin generation assay (TGA) in platelet-poor plasma to assess the contribution of the protein C system to the hypercoagulation development in patients with coronary heart disease (CHD) after intracorona
Externí odkaz:
https://doaj.org/article/35db9273d51d46b19d719200a539b975
Autor:
A. P. Polyakova, V. M. Shmeleva, M. N. Blinov, V. E. Soldatenkov, V. D. Kargin, L. P. Papayan, S. I. Kapustin
Publikováno v:
Медицинская иммунология, Vol 16, Iss 2, Pp 155-164 (2014)
Taking into account interrelations between inflammation and hemostasis, as well as immediate effects of IL-1β, IL-6 and TNFα upon blood coagulation system, one may suggest that their functional variantscould determine thrombosis risks both in arter
Externí odkaz:
https://doaj.org/article/a55034da8bce406eb141fbbe2c6f4874
Publikováno v:
Вестник хирургии имени И.И. Грекова, Vol 174, Iss 4, Pp 77-79 (2015)
The article presents an assessment of anticoagulant effect of rivaroxaban in 35 patients with thromboembolic diseases. The results of expressed anticoagulant effect of rivaroxaban were obtained during a day (or more). The data of increase in sensitiv
Externí odkaz:
https://doaj.org/article/e7fcedf3d4a743a580c91271baebf383
Autor:
S I Kapustin, M N Blinov, V D Kargin, L I Filanovskaya, N В Saltykova, O E Belyazo, O G Golovina, V M Shmeleva, A M Panshina, L P Papayan
Publikováno v:
Терапевтический архив, Vol 78, Iss 10, Pp 78-79 (2003)
Aim. To study the role of genetic determinants of hereditary thrombophilia in pathogenesis of various clinical manifestations of venous thrombosis in the citizens of the North-West Region of Russia. Material and methods. Mutations of the genes of fac
Externí odkaz:
https://doaj.org/article/f7778be27a0d40e7a63555ebeff377b0
Autor:
V. E. Soldatenkov, L. P. Papayan, S. I. Kapustin, A. I. Tomchemko, V. D. Kargin, A. V. Chechulova, V. V. Soroka
Publikováno v:
Flebologiia. 14:6
Autor:
S. I. Kapustin, L. P. Papayan, V. D. Kargin, V. M. Shmeleva, A. P. Polyakova, M. N. Blinov, V. E. Soldatenkov
Publikováno v:
Medicinskaâ Immunologiâ, Vol 16, Iss 2, Pp 155-164 (2014)
Taking into account interrelations between inflammation and hemostasis, as well as immediate effects of IL-1β, IL-6 and TNFα upon blood coagulation system, one may suggest that their functional variants could determine thrombosis risks both in arte
Autor:
A. N. Mamaev, T. V. Vavilova, M. G. Nikolaeva, T. M. Korzo, S. A. Bobrov, I. E. Zazerskaya, V. V. Romanov, A. P. Momot, E. A. Kornyushina, M. S. Zajnulina, L. P. Papayan
Publikováno v:
Laboratornaya sluzhba. 8:55
Autor:
A. S. Shitikova, Z. D. Fedorova, O. E. Belyazo, G. P. Shlyapochnikova, L. P. Papayan, L. A. Denisova, V. A. Egorova, T. I. Popova
Publikováno v:
Kazan medical journal. 68:124-130
Bernard-Soulier disease, a congenital macrocytic thrombocytopathy, was first described in 1948. Currently, this pathology has again attracted the attention of many researchers, as the study of its pathogenesis has deepened the understanding of the me